Literature DB >> 33622064

History of genome editing: From meganucleases to CRISPR.

Simon E Tröder1, Branko Zevnik1.   

Abstract

CRISPR-mediated genome editing has undoubtedly revolutionized genetic engineering of animals. With the ability for virtually unlimited modification of almost any genome it is easy to forget which amazing discoveries paved the way for this ground-breaking technology. Here, we summarize the history of genome editing platforms, starting from enhanced integration of foreign DNA by meganuclease-mediated double-strand breaks to CRISPR/Cas9, the leading technology to date, and its re-engineered variants.

Entities:  

Keywords:  Animal model; GM models; genetic engineering; genetics; genome editing; organisms and models

Mesh:

Year:  2021        PMID: 33622064     DOI: 10.1177/0023677221994613

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  7 in total

Review 1.  The Pitfalls of in vivo Cardiac Physiology in Genetically Modified Mice - Lessons Learnt the Hard Way in the Creatine Kinase System.

Authors:  Craig A Lygate
Journal:  Front Physiol       Date:  2021-05-14       Impact factor: 4.566

2.  A simple and economic protocol for efficient in vitro fertilization using cryopreserved mouse sperm.

Authors:  Magdalena Wigger; Simon E Tröder; Branko Zevnik
Journal:  PLoS One       Date:  2021-10-28       Impact factor: 3.240

Review 3.  Advances in Modeling Polyglutamine Diseases Using Genome Editing Tools.

Authors:  Marianna Karwacka; Marta Olejniczak
Journal:  Cells       Date:  2022-02-02       Impact factor: 6.600

4.  Inhibition of HIV-1 replication using the CRISPR/cas9-no NLS system as a prophylactic strategy.

Authors:  Ali Salimi-Jeda; Maryam Esghaei; Farah Bokharaei-Salim; Ali Teimoori; Asghar Abdoli
Journal:  Heliyon       Date:  2022-08-31

Review 5.  Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing.

Authors:  Dito Anurogo; Nova Yuli Prasetyo Budi; Mai-Huong Thi Ngo; Yen-Hua Huang; Jeanne Adiwinata Pawitan
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

Review 6.  Genome editing via non-viral delivery platforms: current progress in personalized cancer therapy.

Authors:  Tianxia Lan; Haiying Que; Min Luo; Xia Zhao; Xiawei Wei
Journal:  Mol Cancer       Date:  2022-03-11       Impact factor: 27.401

7.  Screening and validation of genome-edited animals.

Authors:  Rosie K Bunton-Stasyshyn; Gemma F Codner; Lydia Teboul
Journal:  Lab Anim       Date:  2021-07-01       Impact factor: 2.471

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.